Upon intravenous administration, this virus blocked CXCL12/CXCR4 signaling, inhibiting the recruitment of circulating endothelial progenitors (CEPs) into the stroma and destructing the tumor vasculature in human breast tumor bearing mice [97]. Here, CXCR4 is linked to breast neoplasm.